key: cord-0983957-lv8jdo6o
authors: Leong, Leanne Ca-Yin; Hong, Wei-Zhen; Khatri, Priyanka
title: Reactivation of Minimal Change Disease and IgA Nephropathy after COVID-19 Vaccination
date: 2021-12-01
journal: Clin Kidney J
DOI: 10.1093/ckj/sfab241
sha: 6e101e85ef93f325c3948ec4478da59cee84a022
doc_id: 983957
cord_uid: lv8jdo6o

nan

.

There is a possible role of T-cell mediated immune dysregulation precipitated by mRNA vaccination leading to glomerular disease flares 3 . Further research is warranted in this area.

Adequate patient counselling and monitoring for early relapse should be vigilantly practised by managing nephrologists following COVID-19 vaccination.

We obtained informed consent from the patients to publish their case. 

Relapse of Minimal Change Disease Following the Pfizer-BioNTech COVID-19 Vaccine

Gross hematuria following vaccination for severe acute respiratory syndrome coronavirus 2 in 2 patients with IgA nephropathy

COVID-19 vaccine BNT162b1 elicits human antibody and T H 1 T cell responses

None declared.